BioSpace News Archive

Bivalirudin Drug Market New Development and Competitive Analysis Report: Global Industry Analysis

Bivalirudin is a synthetic residue peptide and it is direct thrombin inhibitor. It is an anticoagulant that helps to prevent the formation of blood clots, especially in people with severe chest pain or ones who are undergoing angioplasty.

March 3, 2022
·
6 min read
Abetalipoproteinemia Monitoring Systems Market: Molecular genetic testing segment is projected to grow at a rapid pace during the forecast period

Albany NY, United States: Abetalipoproteinemia is an inborn metabolic disorder. It has a heterogeneous interpreted clinical presentation.

March 3, 2022
·
5 min read
Drug Development

Nirsevimab significantly protected infants against RSV disease in Phase 3 trial

The New England Journal of Medicine published detailed results from a Phase 3 trial evaluating nirsevimab, the first investigational long-acting antibody designed to protect all infants across the respiratory syncytial virus season with a single dose.

March 3, 2022
·
16 min read
Emollivet launches spray for equestrian pastern dermatitis

Emollivet, a subsidiary of Lipidor AB, is now launching Emollivet COMBI: an antiseptic emollient spray for horses with pastern dermatitis.

March 3, 2022
·
2 min read
Clover to Participate at Upcoming Investor Conferences - Mar 03, 2022

Clover Biopharmaceuticals, Ltd., a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates, announced its participation in three upcoming investor conferences.

March 3, 2022
·
3 min read
Genetown

Concert Pharmaceuticals Reports 2021 Financial Results and Provides Company Update

Concert Pharmaceuticals, Inc. reported financial results for the year ended December 31, 2021.

March 3, 2022
·
9 min read
Policy

Clinical trial waiver in China opens door to 2022 registration filing for ALK’s dust mite allergy tablet

ALK announced that it expects to submit a registration application in China for its house dust mite sublingual allergy immunotherapy tablet already in 2022.

March 3, 2022
·
2 min read
BioMidwest

Acibadem Group Purchases Second MRIdian® System for Acibadem Altunizade Hospital in Istanbul

ViewRay, Inc. announced that the Acibadem Group, one of the leading private healthcare service institutions in Turkey, has purchased a second MRIdian MRI-guided radiation therapy system for installation at the Acibadem Altunizade Hospital in Istanbul, Turkey.

March 3, 2022
·
6 min read
Business

BIOLASE to Report Fourth Quarter and Full Year 2021 Results on March 17, 2022

BIOLASE, Inc. announced that it will release fourth quarter and full-year 2021 financial and operating results on Thursday, March 17, 2022 after the close of the U.S. financial markets and will host a conference call and webcast that day at 4:30 p.m. ET / 1:30 p.m.

March 3, 2022
·
2 min read
Business

Adrestia Appoints Robert Johnson as Chief Executive Officer

Adrestia Therapeutics today announced the appointment of life sciences executive Robert Johnson as Chief Executive Officer.

March 3, 2022
·
6 min read